Nav: Home

Heart valve procedure safe for patients with common heart defect

June 11, 2019

LOS ANGELES (EMBARGOED UNTIL JUNE 11, 2019 at 11 A.M. EDT) -- A new analysis conducted by investigators at the Cedars-Sinai Smidt Heart Institute shows for the first time that patients with a common heart defect who undergo catheter-based valve replacement procedures have the same survival and complication rates as patients without the defect who undergo the same procedure.

Published June 11 in JAMA: The Journal of the American Medical Association, the analysis compares outcomes for 2,726 patients born with a bicuspid aortic valve-two leaflets that open and close with every heartbeat-with 79,096 patients born with the normal three leaflets on their aortic valves. Both groups of patients were diagnosed with aortic stenosis, a stiffness of the valve's leaflets that reduces the ability to fully open and close and causes the heart's aortic valve to narrow and the heart muscle to become thicker and sometimes weaker.

Aortic stenosis usually affects people 60 and older, but patients born with bicuspid aortic valve often experience it at a younger age. About 1% of the population is born with bicuspid aortic valve.

TAVR (transcatheter aortic valve replacement) is a minimally invasive, catheter-based procedure during which an interventional cardiologist repairs the valve by placing a new valve into the aorta. For patients with normal aortic valves, the procedure is generally considered less risky and easier to recover from than open-heart surgery. But until now, there was not enough data to prove the TAVR procedure also is safe for patients with bicuspid valves.

"In our analysis, we looked at all the bicuspid anatomy patients and found that death rates were no different than patients who had the normal number of leaflets and TAVR," said Raj Makkar, MD, vice president of Cardiovascular Innovation and Intervention at Cedars-Sinai and the Stephen R. Corday Chair in Interventional Cardiology. "This is important because many of the pivotal studies on TAVR did not include bicuspid patients due to concern that these valves may not expand and work in fish-mouth like narrowing in bicuspid anatomy."

The analysis also showed that bicuspid patients were slightly more likely than tricuspid patients to have a stroke within 30 days of the procedure. Based on these findings, Makkar says "carefully selected patients with bicuspid aortic valve stenosis can be treated with TAVR, sparing them more invasive open-heart surgery and longer recovery times since most patients can be discharged home the day after the procedure."

Makkar's TAVR analysis of patients at 552 U.S. medical centers showed:
  • 2.6% of bicuspid patients died within 30 days of the procedure, compared to 2.5% of tricuspid patients, a difference that is not statistically significant.

  • 10.5% of bicuspid patients died within one year of the procedure, compared to 12% of tricuspid patients, a difference that is not statistically significant.

  • The 30-day stroke rate was higher for bicuspid patients (2.5%) than for tricuspid patients (1.6%).

  • The risk of procedural complications requiring open-heart surgery was significantly higher in the bicuspid group (0.9%) than the tricuspid cohort (0.4%).

  • Both groups experienced the same quality of life as measured by the Kansas City Cardiomyopathy Questionnaire.
"This study highlights a critical evaluation that may help some patients avoid unnecessary surgery and complications," said Eduardo Marbán, MD, PhD, director of the Smidt Heart Institute. "Here at Cedars-Sinai, we put the patient first. Many, but not all, patients with bicuspid aortic valve are candidates for TAVR. The care of each patient is individualized, and those who would benefit more from surgery will be appropriately managed by the appropriate faculty on our team."
-end-
Read more on the Cedars-Sinai blog: A Fresh Start After Open-Heart Surgery

Cedars-Sinai Medical Center

Related Aortic Valve Articles:

Public reporting on aortic valve surgeries has decreased access, study finds
Public reporting on aortic valve replacement outcomes has resulted in fewer valve surgeries for people with endocarditis, a new study has found.
Bioengineers explore cardiac tissue remodeling after aortic valve replacement procedures
Researchers have developed biomaterial-based 'mimics' of heart tissues to measure patients' responses to an aortic valve replacement procedure, offering new insight into the ways that cardiac tissue re-shapes itself post-surgery.
New research addresses incidence of atrial fibrillation after aortic valve replacement
UAB investigators have outlined the incidence and implications of atrial fibrillation after transcatheter aortic valve implantation and surgical aortic valve replacement.
Defects in heart valve cilia during fetal development cause mitral valve prolapse
Genetic mutations in heart valve cells of the developing fetus lead to mitral valve prolapse, report a global collaborative of researchers, including Medical University of South Carolina investigators, in today's Science Translational Medicine.
PCR statement on evolving indications for transcatheter aortic valve implantation
Paris, France, 21 May 2019. Severe symptomatic aortic stenosis, a degenerative disease-causing calcification and immobility of the aortic valve leaflets leading to left ventricular outflow obstruction, is the most common valve lesion leading to intervention in Europe and the USA.
Trans-catheter aortic valve replacement can improve outcomes in low-risk surgical patients
A new study examines the effects of TAVR with a balloon-expandable valve for low-risk patients.
Researchers uncover new cause of abdominal aortic aneurysm
Researchers have discovered that a family of lipids (fats) contribute to the development of a serious aortic disease, by driving clotting in the blood vessel wall.
Early valve replacement versus watchful waiting in patients with severe aortic stenosis
Patients with severe aortic stenosis who have no symptoms may benefit more from an aggressive strategy of early valve replacement than from a conservative watch-and-wait approach, according to new research published today online in The Annals of Thoracic Surgery.
Low-risk patients benefit from minimally invasive transcatheter aortic valve replacement
Results from a New England Journal of Medicine paper, released March 17 and co-authored by S.
Transcatheter valve replacement safe in those with unusual valve anatomy
Compared with patients who had a typical tricuspid aortic valve, patients with a more unusual bicuspid aortic valve had a similar rate of death but a higher likelihood of stroke after undergoing a procedure to replace the valve by threading surgical equipment through an artery, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.
More Aortic Valve News and Aortic Valve Current Events

Top Science Podcasts

We have hand picked the top science podcasts of 2019.
Now Playing: TED Radio Hour

In & Out Of Love
We think of love as a mysterious, unknowable force. Something that happens to us. But what if we could control it? This hour, TED speakers on whether we can decide to fall in — and out of — love. Guests include writer Mandy Len Catron, biological anthropologist Helen Fisher, musician Dessa, One Love CEO Katie Hood, and psychologist Guy Winch.
Now Playing: Science for the People

#542 Climate Doomsday
Have you heard? Climate change. We did it. And it's bad. It's going to be worse. We are already suffering the effects of it in many ways. How should we TALK about the dangers we are facing, though? Should we get people good and scared? Or give them hope? Or both? Host Bethany Brookshire talks with David Wallace-Wells and Sheril Kirschenbaum to find out. This episode is hosted by Bethany Brookshire, science writer from Science News. Related links: Why Climate Disasters Might Not Boost Public Engagement on Climate Change on The New York Times by Andrew Revkin The other kind...
Now Playing: Radiolab

An Announcement from Radiolab